Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?

Beggiato, Sarah; Zuccarini, Mariachiara; Cassano, Tommaso; Borroto-Escuela, Dasiel Oscar; Di Iorio, Patrizia; Schwarcz, Robert; Fuxe, Kjell; Ferraro, Luca

Beggiato, Sarah; Zuccarini, Mariachiara; Cassano, Tommaso; Borroto-Escuela, Dasiel Oscar; Di Iorio, Patrizia; Schwarcz, Robert; Fuxe, Kjell; Ferraro, Luca.

Afiliação

Beggiato S; Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.
Zuccarini M; Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.
Cassano T; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Borroto-Escuela DO; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Di Iorio P; Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.
Schwarcz R; Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States.
Fuxe K; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ferraro L; Department of Life Sciences and Biotechnology and LTTA Center, University of Ferrara, Ferrara, Italy.

Front Pharmacol ; 12: 654426, 2021.

Article em En | MEDLINE | ID: mdl-33935767

Palavras-chave

adenosine A1 and A2A receptors; cognition; combinatory therapy; kynurenine pathway; receptor heteromers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google